Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials Post author:Sam Post published:November 12, 2017 Post category:BioPharma Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace You Might Also Like OrbiMed To Raise $450 Million For Third Asia Life Science Fund March 2, 2017 Eli Lilly Insulin Drug Price Tripled While Trump's HHS Nominee Was President of the U.S. Unit November 16, 2017 Acelity Names As Chief Financial Officer June 12, 2017
Eli Lilly Insulin Drug Price Tripled While Trump's HHS Nominee Was President of the U.S. Unit November 16, 2017